Covered recipient · General Payments record
LINDY KUEHNER NETTLETON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,879.83
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $868.24 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $443.06 | 30 |
| PFIZER INC. | $74.10 | 4 |
| GlaxoSmithKline, LLC. | $72.31 | 4 |
| Lilly USA, LLC | $67.77 | 4 |
| Acerta Pharma LLC | $53.75 | 3 |
| Vanda Pharmaceuticals Inc. | $48.94 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $43.74 | 2 |
| Phathom Pharmaceuticals, Inc. | $30.80 | 2 |
| Novo Nordisk AS | $18.45 | 1 |
| Amgen Inc. | $15.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.92 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112090 | CMS |
| ABBVIE INC. | $9.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112092 | CMS |
| ABBVIE INC. | $10.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112094 | CMS |
| ABBVIE INC. | $24.42 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112096 | CMS |
| ABBVIE INC. | $9.93 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112098 | CMS |
| ABBVIE INC. | $2.64 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112100 | CMS |
| ABBVIE INC. | $8.12 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112102 | CMS |
| ABBVIE INC. | $15.09 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112104 | CMS |
| ABBVIE INC. | $26.07 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112106 | CMS |
| ABBVIE INC. | $0.36 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112108 | CMS |
| ABBVIE INC. | $16.59 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112110 | CMS |
| ABBVIE INC. | $15.50 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112112 | CMS |
| ABBVIE INC. | $3.29 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112114 | CMS |
| ABBVIE INC. | $17.88 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112116 | CMS |
| ABBVIE INC. | $24.29 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112118 | CMS |
| ABBVIE INC. | $21.27 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112120 | CMS |
| ABBVIE INC. | $11.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112122 | CMS |
| ABBVIE INC. | $0.43 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112124 | CMS |
| ABBVIE INC. | $11.16 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112126 | CMS |
| ABBVIE INC. | $15.87 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112128 | CMS |
| ABBVIE INC. | $15.76 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112130 | CMS |
| ABBVIE INC. | $20.26 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112132 | CMS |
| ABBVIE INC. | $20.18 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112134 | CMS |
| ABBVIE INC. | $12.41 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112136 | CMS |
| ABBVIE INC. | $14.43 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112138 | CMS |
| ABBVIE INC. | $17.91 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112140 | CMS |
| ABBVIE INC. | $13.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112142 | CMS |
| ABBVIE INC. | $14.25 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112144 | CMS |
| ABBVIE INC. | $24.15 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112146 | CMS |
| ABBVIE INC. | $20.38 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112148 | CMS |
| Amgen Inc. | $15.32 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111661405 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.61 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104696516 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.31 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104251001 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.83 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104573652 | CMS |
| GlaxoSmithKline, LLC. | $18.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115930563 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116635938 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116312261 | CMS |
| GlaxoSmithKline, LLC. | $19.74 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116297758 | CMS |
| Lilly USA, LLC | $16.20 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135156951 | CMS |
| Lilly USA, LLC | $17.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135136336 | CMS |
| Lilly USA, LLC | $15.92 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135136338 | CMS |
| Lilly USA, LLC | $17.85 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135143787 | CMS |
| Novartis Pharmaceuticals Corporation | $22.29 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087135352 | CMS |
| Novartis Pharmaceuticals Corporation | $21.45 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087135354 | CMS |
| Novo Nordisk Inc | $18.45 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097092804 | CMS |
| PFIZER INC. | $16.50 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131732916 | CMS |
| PFIZER INC. | $18.28 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131882444 | CMS |
| PFIZER INC. | $21.32 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131194577 | CMS |
| PFIZER INC. | $18.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131001107 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.74 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151101965 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.06 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151101967 | CMS |
| Vanda Pharmaceuticals Inc. | $32.25 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133914201 | CMS |
| Vanda Pharmaceuticals Inc. | $16.69 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133914203 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.